A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene.
ACTIVE_NOT_RECRUITING
Status
Conditions
- Carcinoma, Pancreatic Ductal
- Colorectal Neoplasms
- Carcinoma, Non-Small-Cell Lung
Interventions
- DRUG: PF-07985045
- COMBINATION_PRODUCT: Gemcitabine
- COMBINATION_PRODUCT: Nab-paclitaxel
- COMBINATION_PRODUCT: Cetuximab
- COMBINATION_PRODUCT: Fluorouracil
- COMBINATION_PRODUCT: Oxaliplatin
- COMBINATION_PRODUCT: Leucovorin
- COMBINATION_PRODUCT: Bevacizumab
- COMBINATION_PRODUCT: Pembrolizumab
- COMBINATION_PRODUCT: Sasanlimab
- COMBINATION_PRODUCT: pemetrexed
- COMBINATION_PRODUCT: Cisplatin
- COMBINATION_PRODUCT: Paclitaxel
- COMBINATION_PRODUCT: Carboplatin
- COMBINATION_PRODUCT: PF-07284892
Sponsor
Pfizer